Stockreport

Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024

Ventyx Biosciences, Inc.  (VTYX) 
PDF SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel [Read more]